Kernal Biologics
YC S20Boston, US · Founded 2016 · Delaware corporation · 20 employees · 9 known investors
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesArtificial IntelligenceGenomicsUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S20)
Kernal Biologics was founded in 2016 by Yusuf Erkul, Jeff Ozdemir, Burak Yilmaz, and Burak YILMAZ.
YE
Yusuf Erkulin𝕏Co-founder, CEOHe previously worked at Merck on oncology drug discovery and development, holds an M.D. from Hacettepe University, a B.S. in Biology from MIT, and an executive MBA from MIT Sloan.
JO
Jeff OzdemirinCo-founder · Head of PlatformJeff Ozdemir holds a PhD in Molecular Genetics from UT Southwestern Medical Center and completed postdoctoral training at Harvard Medical School. He previously taught biochemistry at MIT before co-founding Kernal Biologics.
BY
Burak YilmazinFounder & PresidentBurak Yilmaz holds an MS and is co-founder and lead designer at Kernal Biologics, where he works on mRNA platform technology. Previously, he founded Sentegen/Sentebiolab, a synthetic biology company focused on synthetic DNA production for research and diagnostics.
BY
Burak YILMAZinFounder & PresidentBurak Yilmaz holds an MS and previously founded Sentegen/Sentebiolab, a synthetic biology company focused on synthetic DNA production for research and diagnostics. He is co-founder and lead designer of Kernal Biologics, which develops mRNA-based therapeutics for cancer and other serious diseases.
CM
Catherine MoroskiExecutive
OY
Oguzhan YilmasNamed on SEC filing
Investors · 9
Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
FoundersX VenturesSilicon Valley
HOF CapitalNew York · $25K – $15M
Hummingbird VenturesSingapore · $500K – $10M
SAV (Scale Asia Ventures)Palo Alto
Y CombinatorSan Francisco · $500K
Also in the syndicate · 2
AmgenHummingbird
Reported raises · per SEC filings
Form D private placements$20.9M disclosed across 3 of 4 rounds · 2016–2025
▶$20.1MraisedFeb 2022 · 53 investors · BiotechnologyRule 506(b)
▶$20.1MraisedFeb 2022 · 53 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yusuf ErkulExecutive Officer, Director
- Burak YilmazExecutive Officer, Director
- Offering amount
- $25.5M
- Amount sold
- $20.1M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedAug 2018 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Burak YilmazExecutive Officer
- Yusuf ErkulExecutive Officer, Director
- Oguzhan YilmazDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$350KraisedSep 2016 · 2 investors · Other Health CareRule 506(b)
▶$350KraisedSep 2016 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Yusuf ErkulExecutive Officer, Director
- Catherine MoroskiExecutive Officer, Director
- Oguzhan YilmasDirector
- Offering amount
- $350K
- Amount sold
- $350K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Kernal Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Kernal Biologics do?
- Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
- Who founded Kernal Biologics?
- Kernal Biologics was founded by Yusuf Erkul, Jeff Ozdemir, Burak Yilmaz, Burak YILMAZ in 2016.
- Who are Kernal Biologics's investors?
- Kernal Biologics's investors include Asymmetry Ventures, Civilization Ventures Management, Llc, FoundersX Ventures, HOF Capital, Hummingbird Ventures, SAV (Scale Asia Ventures), Y Combinator.
- How much funding has Kernal Biologics raised?
- Kernal Biologics has disclosed $20.9M raised across 3 of its 4 known rounds.
- Where is Kernal Biologics headquartered?
- Kernal Biologics is headquartered in Boston, US.